The neurological manifestations of Gaucher disease type 1: The French Observatoire on Gaucher disease (FROG)

Journal of Inherited Metabolic Disease

Volumn 33, Issue 4, 2010, Pages 331-338

  Cherin P ^a   Rose, C ^b   De Roux Serratrice, C ^c   Tardy, D ^d   Dobbelaere, D ^e   Grosbois, B ^f   Hachulla, E ^e   Jaussaud, R ^g   Javier, R M ^h   Noel E ⁱ   Clerson, P ^j   Hartmann, A ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

^c TIMONE HOSPITAL   (France)

^d Actelion Pharmaceuticals France   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f SERVICE DE RHUMATOLOGIE   (France)

^g SERVICE DE DERMATOLOGIE   (France)

^h HÔPITAL DE HAUTEPIERRE   (France)

ⁱ HÔPITAL CIVIL   (France)

^j Orgametrie   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FRANCE; GAUCHER DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE FIBER; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PREVALENCE; CROSS-SECTIONAL STUDY; DEPRESSIVE DISORDER; GENETICS; GENOTYPE; HEALTH SURVEY; MIDDLE AGED; PARKINSONIAN DISORDERS; PERIPHERAL NERVOUS SYSTEM DISEASES;

ADULT; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; FRANCE; GAUCHER DISEASE; GENOTYPE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE;

EID: 77956059558     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9095-5     Document Type: Article

References (40)

1. J Aharon-Peretz H Rosenbaum R Gershoni-Baruch 2004 Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews N Engl J Med 351 1972 1977 10.1056/NEJMoa033277 1:CAS:528:DC%2BD2cXps1Wksbc%3D 15525722
2. B Bembi S Zambito Marsala, et al. 2003 Gaucher's disease with Parkinson's disease: clinical and pathological aspects Neurology 61 99 101 1:STN:280:DC%2BD3szhvVSltA%3D%3D 12847165
3. M Biegstraaten IN Van Schaik JM Aerts CE Hollak 2008 Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature J Inherit Metab Dis 31 337 349 10.1007/s10545-008-0832-y 1:STN:280:DC%2BD1czovFegsg%3D%3D 18404411
4. A Bischoff FW Reutter T Wegmann 1967 Peripheral nervous system diseases in morbus Gaucher. New data based on electronmicroscopy Schweiz Med Wochenschr 97 1139 1146 1:STN:280:DyaF1czlsVKlsA%3D%3D 4298883
5. A Brautbar D Elstein G Pines, et al. 2004 Effect of enzyme replacement therapy on gammopathies in Gaucher disease Blood Cells Mol Dis 32 214 217 10.1016/j.bcmd.2003.10.007 1:CAS:528:DC%2BD2cXntVGqug%3D%3D 14757437
6. Butler E, Grabowski GA (2001) Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, vol 3, 8th edn. McGraw-Hill, New York, pp 3635-3668
7. JL Capablo SA de Cabezón J Fraile P Alfonso M Pocovi P Giraldo 2008 Spanish Group on Gaucher Disease. Neurological evaluation of patients with Gaucher disease diagnosed as type 1 J Neurol Neurosurg Psychiatry 79 219 222 10.1136/jnnp.2006.111518 1:STN:280:DC%2BD1c%2FlsFCgsg%3D%3D 17682016
8. J Charrow HC Andersson P Kaplan, et al. 2000 The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease Arch Intern Med 160 2835 2843 10.1001/archinte.160.18.2835 1:STN:280: DC%2BD3cvnvVelsQ%3D%3D 11025794
9. P Cherin F Sedel C Mignot, et al. 2006 Neurological manifestations of type 1 Gaucher's disease: is a revision of disease classification needed? Rev Neurol (Paris) 162 1076 1083 1:STN:280:DC%2BD28nlt1ekug%3D%3D
10. FY Chov W Zhang HP Shi A Zay T Campbell N Tang P Ferreira 2007 Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles Blood Cells Mol Dis 38 287 293 10.1016/j.bcmd.2006.11.003
11. LN Clark A Nicolai S Afridi, et al. 2005 Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity Mov Disord 20 100 103 10.1002/mds.20320 15517591
12. T Cox R Lachmann C Hollak, et al. 2000 Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis Lancet 355 1481 1485 10.1016/S0140-6736(00)02161-9 1:CAS:528:DC%2BD3cXjt1alt7g%3D 10801168
13. M de Fost TA Out FA de Wilde, et al. 2008 Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature Ann Hematol 87 439 449 10.1007/s00277-008-0441-8 1:CAS:528:DC%2BD1cXkvFSjtr8%3D 18274746
14. A Elbaz JH Bower BJ Peterson, et al. 2003 Survival study of Parkinson disease in Olmsted County, Minnesota Arch Neurol 60 91 96 10.1001/archneur.60.1. 91 12533094
15. A Erikson H Forsberg M Nilsson M Aström JE Månsson 2006 Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease Acta Paediatr 95 312 317 10.1080/08035250500423804 16497642
16. Z Gan-Or N Giladi U Rozovski, et al. 2008 Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset Neurology 70 2277 2783 10.1212/01.wnl.0000304039.11891.29 1:CAS:528:DC%2BD1cXmsFylsrk%3D 18434642
17. DP Germain 2004 Gaucher's disease: a paradigm for interventional genetics Clin Genet 65 77 86 10.1111/j.0009-9163.2004.00217.x 1:STN:280: DC%2BD2c%2FpvFSnsw%3D%3D 14984463
18. Grabowski G, Kolodny E, Weinreb N et al (2006) Gaucher disease: phenotypic and genetic variation. In: Scriver CR, Al Beaudet, Valle D, Slye WS (eds) The online metabolic and molecular basis of inherited metabolic disease. McGraw-Hill Publishers, New York, Chapter 146.1
19. RP Grewal SH Doppelt MA Thompson D Katz RO Brady NW Barton 1991 Neurologic complications of nonneuronopathic Gaucher's disease Arch Neurol 48 1271 1272 1:STN:280:DyaK3s3mtlygsw%3D%3D 1845033
20. B Grosbois C Rose E Noël C Serratrice D Dobbelaere V Gressin P Cherin, et al. 2009 Investigators of the French Observatoire on Gaucher Disease. Gaucher disease and monoclonal gammopathy: a report of 17 cases and impact of therapy Blood Cells Mol Dis 43 138 139 10.1016/j.bcmd.2009.04.002 19427246
21. A Halperin D Elstein A Zimran 2007 Are symptoms of peripheral neuropathy more prevalent in patients with Gaucher disease? Acta Neurol Scand 115 275 278 10.1111/j.1600-0404.2006.00774.x 1:STN:280:DC%2BD2s7ns1emtw%3D%3D 17376127
22. Hollak CEM, Biegstraaten M, van Shaik IN, et al. (2007)Prevalence of polyneuropathy in adult Type 1 Gaucher disease (GD1): a multinational prospective observational study. Annual Congress of the SSIEM, Hamburg, Germany, September 4-7
23. IGPSG 1995 Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Italian General Practitioner Study Group (IGPSG) Neurology 45 1832 1836
24. R Jaussaud 2006 The "French Observatoire" on Gaucher's disease Eur J Intern Med 17 56 58
25. M Machaczka M Rucinska AB Skotnicki W Jurczak 1999 Parkinson-s syndrome preceding clinical manifestation of Gaucher's disease Am J Hematol 61 216 217 10.1002/(SICI)1096-8652(199907)61:3<216::AID-AJH12>3.0.CO;2-B 1:STN:280:DyaK1MzislWnsA%3D%3D 10398575
26. RO McKeran P Bradbury D Taylor G Stern 1985 Neurological involvement in type 1 (adult) Gaucher's disease J Neurol Neurosurg Psychiatry 48 172 175 10.1136/jnnp.48.2.172 1:STN:280:DyaL2M7lvFKntw%3D%3D 3981177
27. RS Markin FM Skultety 1984 Spinal cord compression secondary to Gaucher's disease Surg Neurol 21 341 346 10.1016/0090-3019(84)90111-3 1:STN:280:DyaL2c7kslCntw%3D%3D 6701766
28. A Mygland P Monstad 2001 Chronic polyneuropathies in Vest-Agder, Norway Eur J Neurol 8 157 165 10.1046/j.1468-1331.2001.00187.x 1:STN:280: DC%2BD3MzmvFCmtw%3D%3D 11284994
29. T Pan S Kondo W Le J Jankovic 2008 The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease Brain 131 1969 1978 10.1093/brain/awm318 18187492
30. GM Pastores NL Barnett P Bathan EH Kolodny 2003 A neurological symptom survey of patients with type I Gaucher disease J Inherit Metab Dis 26 641 645 10.1023/B:BOLI.0000005623.60471.51 1:STN:280:DC%2BD2c%2FhtVWksA%3D%3D 14707512
31. GM Pastores P Giraldo P Chérin A Mehta 2009 Goal-orientated therapy with miglustat in Gaucher disease Curr Med Res Opin 25 23 37 10.1185/03007990802576518 1:CAS:528:DC%2BD1MXkvFCktrw%3D 19210136
32. F Pico 2001 Descriptive epidemiology of principal neurologic diseases in France Lett Neurol 5 1 3
33. J Pinkhas M Djaldetti M Yaron 1965 Coincidence of multiplemyeloma with Gaucher's disease Isr J Med Sci 1 537 540 1:STN:280:DyaF28%2FjvFequg%3D%3D 5842268
34. EH Kolodny MD Ullman HJ Mankin SS Raghavan J Topol JL Sullivan 1982 Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients Prog Clin Biol Res 95 33 65 1:STN:280:DyaL3s%2FhsFemsg%3D%3D 6289358
35. S Ramchandren RA Lewis 2009 Monoclonal gammopathy and neuropathy Curr Opin Neurol 22 480 485 10.1097/WCO.0b013e32832fd563 19625962
36. E Sidransky 2004 Gaucher disease: complexity in a "simple" disorder Mol Genet Metab 83 6 15 10.1016/j.ymgme.2004.08.015 1:CAS:528:DC%2BD2cXotF2nsb8%3D 15464415
37. MG Schlossmacher V Cullen J Muthing 2005 The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews N Engl J Med 352 728 731 10.1056/NEJM200502173520719 15719451
38. N Tayebi J Walker B Stubblefield, et al. 2003 Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79 104 109 10.1016/S1096-7192(03) 00071-4 1:CAS:528:DC%2BD3sXksVGlt78%3D 12809640
39. K Wong E Sidransky A Verma, et al. 2004 Neuropathology provides clues to the pathophysiology of Gaucher disease Mol Genet Metab 82 192 207 10.1016/j.ymgme.2004.04.011 1:CAS:528:DC%2BD2cXlsVSgu74%3D 15234332
40. SG Ziegler MJ Eblan U Gutti, et al. 2007 Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease Mol Genet Metab 91 195 200 10.1016/j.ymgme.2007.03.004 1:CAS:528:DC%2BD2sXlvVyhtbg%3D 17462935